Literature DB >> 3198938

A large outbreak of mumps in the postvaccine era.

M Wharton1, S L Cochi, R H Hutcheson, J M Bistowish, W Schaffner.   

Abstract

During a county-wide mumps outbreak in Nashville, Tennessee, 332 cases of mumps were identified at a public high school (attack rate, 18.8%). A pep rally 17 d before the peak of the outbreak at a single public high school may have provided an opportunity for point-source exposure. A case-control study demonstrated that vaccine efficacy was 75% (we used provider-verified records and excluded students with a history of mumps disease). Although school records were nonuniform, mumps immunization status was correct, compared with provider-verified records, in at least 85% of both cases and controls. Parental reports were much less reliable. The cost of the outbreak was estimated at $154/case. Receiving mumps vaccine at a vaccine clinic held after the outbreak had peaked was associated with a decrease in risk of mumps disease. Thus, these clinics may have a role in the control of such outbreaks.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3198938     DOI: 10.1093/infdis/158.6.1253

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  25 in total

1.  Mumps: a current epidemiologic pattern as a necessary background for the choice of a vaccination strategy.

Authors:  C Zotti; O Ossola; R Barberis; A Castella; A M Ruggenini
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

2.  The control of mumps in Israel.

Authors:  P E Slater; E Anis; A Leventhal
Journal:  Eur J Epidemiol       Date:  1999-09       Impact factor: 8.082

3.  Clinical economics: a method for prospective health resource data collection.

Authors:  C Copley-Merriman; L Egbuonu-Davis; J G Kotsanos; P Conforti; T Franson; G Gordon
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

4.  Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis.

Authors:  G Palacios; O Jabado; D Cisterna; F de Ory; N Renwick; J E Echevarria; A Castellanos; M Mosquera; M C Freire; R H Campos; W I Lipkin
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  [Mumps in a urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures].

Authors:  R de los Ríos Martín; N García Marín; J Sanz Moreno; E Ballester Orcal
Journal:  Aten Primaria       Date:  2001-06-15       Impact factor: 1.137

Review 6.  Mumps: an Update on Outbreaks, Vaccine Efficacy, and Genomic Diversity.

Authors:  Eugene Lam; Jennifer B Rosen; Jane R Zucker
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

7.  Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.

Authors:  Jeremy Mauldin; Kathryn Carbone; Henry Hsu; Robert Yolken; Steven Rubin
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  Immunizations in pediatrics: an update.

Authors:  E L Ford-Jones; R Gold
Journal:  Can Fam Physician       Date:  1990-09       Impact factor: 3.275

9.  Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Neelam Dhiman; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Pediatrics       Date:  2008-05       Impact factor: 7.124

10.  Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.

Authors:  Cheryl Cohen; Joanne M White; Emma J Savage; Judith R Glynn; Yoon Choi; Nick Andrews; David Brown; Mary E Ramsay
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.